Safety and Tolerability of Recombinant Humanized Anti-PD-1 Monoclonal Antibody Toripalimab for Patients With Advanced Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Shanghai Junshi Bioscience Co., Ltd.
National Cancer Institute (NCI)
Icahn School of Medicine at Mount Sinai
Quadriga Biosciences, Inc.
Merck Sharp & Dohme LLC